Moving Medicine Forward

PureTech is led by a proven and seasoned management team. Collectively, they have overseen the research and development of products supporting 20 regulatory approvals and has been involved in the C-suite of companies acquired for more than $13 billion cumulatively.

Stephen Muniz, Esq
Chief Operating Officer, Member of the Board of Directors
Miscellaneous Information:

Stephen Muniz, Esq., is the chief operating officer at PureTech and has served as a member of PureTech’s board of directors since 2015. Prior to joining PureTech, Mr. Muniz was a partner in the corporate department of Locke Lord LLP, where he practiced law for 10 years. Mr. Muniz’s practice at Locke Lord LLP focused on the representation of life science venture funds as well as their portfolio companies in general corporate matters and in investment and liquidity transactions.

Prior to joining Locke Lord LLP, Mr. Muniz was a law clerk to The Honorable Raya Dreben at the Massachusetts Appeals Court. He was also a Kauffman Entrepreneur Fellow, a program sponsored by the Kauffman Foundation. Mr. Muniz also sits on the board of directors of Entrega, Inc., Follica, Incorporated, and Alivio Therapeutics, Inc. He previously served on the board of directors of Karuna Therapeutics, Inc. and Gelesis, Inc. Mr. Muniz has a BA in economics and accounting from The College of the Holy Cross and a JD from the New England School of Law (NESL) where he graduated summa cum laude. Mr. Muniz was valedictorian of the 1997 NESL Commencement and has been awarded the Amos L. Taylor Award for Excellence in Scholarship, the New England Scholar Award and the NESL Trustee Scholar Award.

Share our vision, creativity & dedication - Join PureTech Health

Share our vision, creativity & dedication.

Join PureTech